4-[4-[4-(2-methylpropyl)phenyl]pyrazol-1-yl]-2-propylpyridine;N-(2-methylpropyl)-4-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]aniline;2-(2-methylpropyl)-5-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]pyridine;N-[5-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]-2-pyridinyl]cyclopropanesulfonamide

C81H96N16O2S — CID 158806037

IUPAC4-[4-[4-(2-methylpropyl)phenyl]pyrazol-1-yl]-2-propylpyridine;N-(2-methylpropyl)-4-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]aniline;2-(2-methylpropyl)-5-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]pyridine;N-[5-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]-2-pyridinyl]cyclopropanesulfonamide
SMILESCCCc1cc(-n2cc(-c3ccc(CC(C)C)cc3)cn2)ccn1.CCCc1cc(-n2cc(-c3ccc(CC(C)C)nc3)cn2)ccn1.CCCc1cc(-n2cc(-c3ccc(NCC(C)C)cc3)cn2)ccn1.CCCc1cc(-n2cc(-c3ccc(NS(=O)(=O)C4CC4)nc3)cn2)ccn1
InChIInChI=1S/C21H26N4.C21H25N3.C20H24N4.C19H21N5O2S/c1-4-5-20-12-21(10-11-22-20)25-15-18(14-24-25)17-6-8-19(9-7-17)23-13-16(2)3;1-4-5-20-13-21(10-11-22-20)24-15-19(14-23-24)18-8-6-17(7-9-18)12-16(2)3;1-4-5-18-11-20(8-9-21-18)24-14-17(13-23-24)16-6-7-19(22-12-16)10-15(2)3;1-2-3-16-10-17(8-9-20-16)24-13-15(12-22-24)14-4-7-19(21-11-14)23-27(25,26)18-5-6-18/h6-12,14-16,23H,4-5,13H2,1-3H3;6-11,13-16H,4-5,12H2,1-3H3;6-9,11-15H,4-5,10H2,1-3H3;4,7-13,18H,2-3,5-6H2,1H3,(H,21,23)
InChIKeyIUBYHGYFSDTOPJ-UHFFFAOYSA-N
MW1357.84 g/mol
LogP17.71
Rot. Bonds26

About 4-[4-[4-(2-methylpropyl)phenyl]pyrazol-1-yl]-2-propylpyridine;N-(2-methylpropyl)-4-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]aniline;2-(2-methylpropyl)-5-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]pyridine;N-[5-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]-2-pyridinyl]cyclopropanesulfonamide

4-[4-[4-(2-methylpropyl)phenyl]pyrazol-1-yl]-2-propylpyridine;N-(2-methylpropyl)-4-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]aniline;2-(2-methylpropyl)-5-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]pyridine;N-[5-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]-2-pyridinyl]cyclopropanesulfonamide (PubChem CID 158806037) has the molecular formula C81H96N16O2S and a molecular weight of 1357.84 g/mol. Its IUPAC name is 4-[4-[4-(2-methylpropyl)phenyl]pyrazol-1-yl]-2-propylpyridine;N-(2-methylpropyl)-4-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]aniline;2-(2-methylpropyl)-5-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]pyridine;N-[5-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]-2-pyridinyl]cyclopropanesulfonamide.

Molecular Properties

Compound Name4-[4-[4-(2-methylpropyl)phenyl]pyrazol-1-yl]-2-propylpyridine;N-(2-methylpropyl)-4-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]aniline;2-(2-methylpropyl)-5-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]pyridine;N-[5-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]-2-pyridinyl]cyclopropanesulfonamide
PubChem CID158806037
Molecular FormulaC81H96N16O2S
Molecular Weight1357.84 g/mol
Exact Mass1356.76
IUPAC Name4-[4-[4-(2-methylpropyl)phenyl]pyrazol-1-yl]-2-propylpyridine;N-(2-methylpropyl)-4-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]aniline;2-(2-methylpropyl)-5-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]pyridine;N-[5-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]-2-pyridinyl]cyclopropanesulfonamide
SMILESCCCc1cc(-n2cc(-c3ccc(CC(C)C)cc3)cn2)ccn1.CCCc1cc(-n2cc(-c3ccc(CC(C)C)nc3)cn2)ccn1.CCCc1cc(-n2cc(-c3ccc(NCC(C)C)cc3)cn2)ccn1.CCCc1cc(-n2cc(-c3ccc(NS(=O)(=O)C4CC4)nc3)cn2)ccn1
InChIInChI=1S/C21H26N4.C21H25N3.C20H24N4.C19H21N5O2S/c1-4-5-20-12-21(10-11-22-20)25-15-18(14-24-25)17-6-8-19(9-7-17)23-13-16(2)3;1-4-5-20-13-21(10-11-22-20)24-15-19(14-23-24)18-8-6-17(7-9-18)12-16(2)3;1-4-5-18-11-20(8-9-21-18)24-14-17(13-23-24)16-6-7-19(22-12-16)10-15(2)3;1-2-3-16-10-17(8-9-20-16)24-13-15(12-22-24)14-4-7-19(21-11-14)23-27(25,26)18-5-6-18/h6-12,14-16,23H,4-5,13H2,1-3H3;6-11,13-16H,4-5,12H2,1-3H3;6-9,11-15H,4-5,10H2,1-3H3;4,7-13,18H,2-3,5-6H2,1H3,(H,21,23)
InChIKeyIUBYHGYFSDTOPJ-UHFFFAOYSA-N
XLogP17.71
TPSA206.82 Ų
H-Bond Donors2
H-Bond Acceptors17
Rotatable Bonds26
Heavy Atoms100
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001357.84
LogP ≤ 517.71
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1017

Analyze 4-[4-[4-(2-methylpropyl)phenyl]pyrazol-1-yl]-2-propylpyridine;N-(2-methylpropyl)-4-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]aniline;2-(2-methylpropyl)-5-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]pyridine;N-[5-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]-2-pyridinyl]cyclopropanesulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[4-[4-(2-methylpropyl)phenyl]pyrazol-1-yl]-2-propylpyridine;N-(2-methylpropyl)-4-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]aniline;2-(2-methylpropyl)-5-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]pyridine;N-[5-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]-2-pyridinyl]cyclopropanesulfonamide?
The IUPAC name of 4-[4-[4-(2-methylpropyl)phenyl]pyrazol-1-yl]-2-propylpyridine;N-(2-methylpropyl)-4-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]aniline;2-(2-methylpropyl)-5-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]pyridine;N-[5-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]-2-pyridinyl]cyclopropanesulfonamide (CID 158806037) is 4-[4-[4-(2-methylpropyl)phenyl]pyrazol-1-yl]-2-propylpyridine;N-(2-methylpropyl)-4-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]aniline;2-(2-methylpropyl)-5-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]pyridine;N-[5-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]-2-pyridinyl]cyclopropanesulfonamide.
What is the SMILES notation for 4-[4-[4-(2-methylpropyl)phenyl]pyrazol-1-yl]-2-propylpyridine;N-(2-methylpropyl)-4-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]aniline;2-(2-methylpropyl)-5-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]pyridine;N-[5-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]-2-pyridinyl]cyclopropanesulfonamide?
The canonical SMILES for 4-[4-[4-(2-methylpropyl)phenyl]pyrazol-1-yl]-2-propylpyridine;N-(2-methylpropyl)-4-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]aniline;2-(2-methylpropyl)-5-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]pyridine;N-[5-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]-2-pyridinyl]cyclopropanesulfonamide is CCCc1cc(-n2cc(-c3ccc(CC(C)C)cc3)cn2)ccn1.CCCc1cc(-n2cc(-c3ccc(CC(C)C)nc3)cn2)ccn1.CCCc1cc(-n2cc(-c3ccc(NCC(C)C)cc3)cn2)ccn1.CCCc1cc(-n2cc(-c3ccc(NS(=O)(=O)C4CC4)nc3)cn2)ccn1.
What is the InChIKey of 4-[4-[4-(2-methylpropyl)phenyl]pyrazol-1-yl]-2-propylpyridine;N-(2-methylpropyl)-4-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]aniline;2-(2-methylpropyl)-5-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]pyridine;N-[5-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]-2-pyridinyl]cyclopropanesulfonamide?
The InChIKey is IUBYHGYFSDTOPJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H26N4.C21H25N3.C20H24N4.C19H21N5O2S/c1-4-5-20-12-21(10-11-22-20)25-15-18(14-24-25)17-6-8-19(9-7-17)23-13-16(2)3;1-4-5-20-13-21(10-11-22-20)24-15-19(14-23-24)18-8-6-17(7-9-18)12-16(2)3;1-4-5-18-11-20(8-9-21-18)24-14-17(13-23-24)16-6-7-19(22-12-16)10-15(2)3;1-2-3-16-10-17(8-9-20-16)24-13-15(12-22-24)14-4-7-19(21-11-14)23-27(25,26)18-5-6-18/h6-12,14-16,23H,4-5,13H2,1-3H3;6-11,13-16H,4-5,12H2,1-3H3;6-9,11-15H,4-5,10H2,1-3H3;4,7-13,18H,2-3,5-6H2,1H3,(H,21,23).
What are the key properties of 4-[4-[4-(2-methylpropyl)phenyl]pyrazol-1-yl]-2-propylpyridine;N-(2-methylpropyl)-4-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]aniline;2-(2-methylpropyl)-5-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]pyridine;N-[5-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]-2-pyridinyl]cyclopropanesulfonamide?
4-[4-[4-(2-methylpropyl)phenyl]pyrazol-1-yl]-2-propylpyridine;N-(2-methylpropyl)-4-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]aniline;2-(2-methylpropyl)-5-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]pyridine;N-[5-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]-2-pyridinyl]cyclopropanesulfonamide has a molecular weight of 1357.84 g/mol, XLogP of 17.71, 26 rotatable bonds, 2 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[4-[4-(2-methylpropyl)phenyl]pyrazol-1-yl]-2-propylpyridine;N-(2-methylpropyl)-4-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]aniline;2-(2-methylpropyl)-5-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]pyridine;N-[5-[1-(2-propyl-4-pyridinyl)pyrazol-4-yl]-2-pyridinyl]cyclopropanesulfonamide is sourced from PubChem (CID 158806037), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).